DK518476A - PROCEDURE FOR REDUCING THE QUANTITY OF A BIOLOGICAL ACTIVE COMPOUND TO ACHIEVE A CERTAIN BIOLOGICAL IMPACT - Google Patents

PROCEDURE FOR REDUCING THE QUANTITY OF A BIOLOGICAL ACTIVE COMPOUND TO ACHIEVE A CERTAIN BIOLOGICAL IMPACT

Info

Publication number
DK518476A
DK518476A DK518476A DK518476A DK518476A DK 518476 A DK518476 A DK 518476A DK 518476 A DK518476 A DK 518476A DK 518476 A DK518476 A DK 518476A DK 518476 A DK518476 A DK 518476A
Authority
DK
Denmark
Prior art keywords
biological
procedure
reducing
achieve
active compound
Prior art date
Application number
DK518476A
Other languages
Danish (da)
Inventor
K G Blixt
R Juhlin
M Tiru
Original Assignee
Kockums Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kockums Chem filed Critical Kockums Chem
Publication of DK518476A publication Critical patent/DK518476A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/12Powders or granules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/015Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/046Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating with the help of a non-organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/65Characterized by the composition of the particulate/core
    • A61K2800/651The particulate/core comprising inorganic material
DK518476A 1976-06-29 1976-11-17 PROCEDURE FOR REDUCING THE QUANTITY OF A BIOLOGICAL ACTIVE COMPOUND TO ACHIEVE A CERTAIN BIOLOGICAL IMPACT DK518476A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607389A SE421042B (en) 1976-06-29 1976-06-29 WANT TO REDUCE THE QUANTITY OF BIOLOGICAL ACTIVE SUBSTANCE REQUIRED FOR SOME BIOLOGICAL EFFECT

Publications (1)

Publication Number Publication Date
DK518476A true DK518476A (en) 1977-12-30

Family

ID=20328328

Family Applications (1)

Application Number Title Priority Date Filing Date
DK518476A DK518476A (en) 1976-06-29 1976-11-17 PROCEDURE FOR REDUCING THE QUANTITY OF A BIOLOGICAL ACTIVE COMPOUND TO ACHIEVE A CERTAIN BIOLOGICAL IMPACT

Country Status (24)

Country Link
JP (1) JPS533512A (en)
AR (1) AR221686A1 (en)
AU (1) AU2611177A (en)
BE (1) BE848892A (en)
CA (1) CA1080500A (en)
DD (1) DD130984A5 (en)
DE (1) DE2652163A1 (en)
DK (1) DK518476A (en)
ES (1) ES460159A1 (en)
FI (1) FI61637C (en)
FR (1) FR2356430A1 (en)
GB (1) GB1572718A (en)
GR (1) GR63669B (en)
IL (1) IL52243A (en)
IN (1) IN145766B (en)
IT (1) IT1064524B (en)
LU (1) LU76238A1 (en)
MC (1) MC1116A1 (en)
NL (1) NL7613404A (en)
NO (1) NO146974C (en)
PL (1) PL199237A1 (en)
PT (1) PT66663B (en)
SE (1) SE421042B (en)
ZA (1) ZA773259B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6026093B2 (en) * 1978-03-14 1985-06-21 住友製薬株式会社 Method for producing gefalnate-containing solid preparation
IT1103817B (en) * 1978-06-27 1985-10-14 Guaber Spa GRANULAR DEODORANT COMPOSITION FOR ASHTRAY
BE886778A (en) * 1979-12-21 1981-06-19 Glaxo Group Ltd MIXTURES OF CEPHALEXIN AND SILICON BIOXIDE TO BE INTRODUCED IN PHARMACEUTICAL CAPSULES
DK204682A (en) * 1981-05-08 1982-11-09 Wellcome Found Perfume-releasing materials
NZ204861A (en) * 1982-07-20 1986-10-08 Nat Res Dev Sustained release device:trace element incorporated in cement
HU191244B (en) * 1984-01-06 1987-01-28 Egyt Gyogyszervegyeszeti Gyar Dust mixture of high propylene-glycol content and process for producing same
HU191245B (en) * 1984-01-06 1987-01-28 Egis Gyogyszergyar,Hu Process for the production of stbale pharmaceutical preparation against ketosis
GB8413191D0 (en) * 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
EP0215136B1 (en) * 1985-09-02 1988-06-22 Artesan Pharma Gesellschaft mit beschränkter Haftung Hexetidin-containing therapeutically active agent, method for its preparation and its use as a vaginal disinfectant
GB8713263D0 (en) * 1987-06-05 1987-07-08 Unilever Plc Spheroidal silica
DE19506141A1 (en) * 1995-02-22 1996-08-29 Hoechst Ag Use of aerogels in pharmacy, cosmetics and crop protection
AU2893097A (en) * 1996-04-29 1997-11-19 Agricultural Academy Of Krakow Oral delivery form having a high absorption efficiency and method for making same
SG71877A1 (en) * 1997-12-19 2000-04-18 Johnson & Johnson Consumer Novel powder compositions
ATE462417T1 (en) * 1998-08-13 2010-04-15 Cima Labs Inc MICROEMULSIONS AS SOLID DOSE FORMS FOR ORAL ADMINISTRATION
CA2758618C (en) * 2009-04-24 2017-03-28 Omya Development Ag Particulate material for controlled release of active ingredients
EP2919903B1 (en) 2012-11-14 2020-07-22 W.R. Grace & CO. - CONN. Compositions containing a biologically active material and a non-ordered inorganic oxide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5235736B2 (en) * 1972-09-27 1977-09-10

Also Published As

Publication number Publication date
FI763304A (en) 1977-12-30
CA1080500A (en) 1980-07-01
PT66663A (en) 1977-07-01
PL199237A1 (en) 1979-07-02
DD130984A5 (en) 1978-05-24
FI61637B (en) 1982-05-31
IN145766B (en) 1978-12-16
SE7607389L (en) 1977-12-30
NO146974C (en) 1983-01-26
FR2356430A1 (en) 1978-01-27
LU76238A1 (en) 1977-05-23
GB1572718A (en) 1980-07-30
JPS533512A (en) 1978-01-13
IT1064524B (en) 1985-02-18
MC1116A1 (en) 1977-08-12
SE421042B (en) 1981-11-23
ZA773259B (en) 1978-04-26
IL52243A (en) 1980-10-26
PT66663B (en) 1978-11-13
FI61637C (en) 1982-09-10
NO146974B (en) 1982-10-04
AR221686A1 (en) 1981-03-13
GR63669B (en) 1979-11-28
DE2652163A1 (en) 1978-01-12
FR2356430B1 (en) 1982-08-13
NL7613404A (en) 1978-01-02
IL52243A0 (en) 1977-08-31
AU2611177A (en) 1978-12-21
BE848892A (en) 1977-03-16
ES460159A1 (en) 1978-10-01
NO763947L (en) 1977-12-30

Similar Documents

Publication Publication Date Title
FI65438B (en) FOERFARANDE FOER FRAMSTAELLNING AV PHARMACOLOGISKT ACTIVE ESTRAR AV PHOSPHONOMYRSYRA
DK518476A (en) PROCEDURE FOR REDUCING THE QUANTITY OF A BIOLOGICAL ACTIVE COMPOUND TO ACHIEVE A CERTAIN BIOLOGICAL IMPACT
ATA273278A (en) DENTAL COMPOUNDS
IT7851821A0 (en) INSECTICIDE COMPOSITION
IT1192580B (en) PROSTAGLANDINE ANALOGS
DK73879A (en) QUATERNAME AMMONIUM COMPOUNDS
GB1546015A (en) Racemization of optically active compound
IT1101450B (en) SULPHONANYLIDE COMPOUNDS AS HERBICIDE COMPOUNDS
DK485777A (en) PROCEDURE FOR THE PREPARATION OF A BIOLOGICAL ACTIVE PREPARATION
DK276178A (en) DOSAGE VALVE
IT7848634A0 (en) DISTRIBUTOR
DK486478A (en) ANTIBACTERIAL ACTIVE COMPOUNDS
NO145057C (en) PESTICIDE SYMMETRIC N-SUBSTITUTED BIS-CARBAMOYLOXIMINO-DISULPHIDE COMPOUNDS
ES492844A0 (en) A PROCEDURE FOR THE PREPARATION OF AN OPTICALLY ACTIVE ARYLOXIAL-NOIC COMPOUND
BE861852A (en) N- (TRIFLUOROMETHYL-3-PHENYL) ALKYL ABTHRANILATE
DK197478A (en) PHOTOPOLYMERIZABLE MASS
IT1095457B (en) OPTICALLY ACTIVE COMPOUNDS
NO147601C (en) ANALOGUE PROCEDURE FOR PREPARING THE THERAPEUTIC ACTIVE COMPOUND L-PYROGLUTAMYL-L-HISTIDYL-GLYCIN
DK512378A (en) DOSAGE VALVE
IT1096650B (en) PROSTAGLANDINE ANALOGS
IT1097276B (en) FUEL CONTAINING ACTIVATED ALUMINUM COMPOUNDS
DK157994C (en) ANALOGY PROCEDURE FOR PREPARING A THERAPEUTIC ACTIVE ALKANOLAMINE COMPOUND
SE7802658L (en) FLUID DISTRIBUTOR
IT1156895B (en) 4-IDROSSI-4-METHYL-CICLOESEN-2-ONE-1 AS A PERFUME COMPONENT
SE7811736L (en) N- (PHOSPHONACETHYL) -L-ASPARAGINIC ACID COMPOUNDS